/
/
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments

Share:

Working Group 1 is proud to announce the publication of two systematic reviews on the use of advanced MR imaging for high-grade glioma treatment response monitoring. Both reviews are published in the Frontiers in Oncology and can be downloaded here (Part 1: Perfusion and Diffusion) and here (Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics).

Both reviews result from impressive efforts by a WG1-team, led by Dr. Otto Henriksen (Rigshospitalet, Copenhagen) and Dr. Thomas Booth (KCL, London). Based on their findings, it appears that advanced MRI techniques show huge promise in treatment response assessment.

With these reviews, WG1 highlights that most monitoring biomarkers require standardized international consensus guidelines, with more facilitation regarding technique implementation and reporting in the clinic.

Finally, the reviews resulted in a press release from KCL, which has been picked up by several international news platforms. Congratulations to the whole team!

Recent News

Newsflash Feb 2023 - ITC for ISMRM

 If you are an Early Career Investigator (ECI) [1] working in a participating Inclusiveness Target Country (ITC) [2], and you are your presenting your work on glioma imaging or on the development of advanced MRI techniques with potential for glioma imaging at the upcoming International...

On behalf of the (new) Webinar Team, we would like to invite GLiMR members and all interested peers to let us know their opinions on planned Webinar content.  Broadly, the plan is to offer ‘clinical need’ and/or ‘technical progress’ oriented...